|
||||||||||
Most epidemiologists are aware of some of the problems with P-values; they combine both effect size and sample size, they are not easy to interpret, in most studies they really have no meaning and in many cases they are simply grossly misleading causing mistakes that can be serious. Misinterpretation of P values has probably led […]
We have over the years provided comments to rules and regulations for data protection. We have especially provided information on the situation in Europe where new regulations is being negotiated. The rules have crucial importance for our access to use of data for research, especially for use of registers like the cancer Registry or the […]
Follow the links below to find 2 recent important documents about use of data for research. These influential bodies (Nature and ScienceEurope) provide strong support for making legislation that allows reuse of data for research. http://www.nature.com/news/privacy-in-the-digital-age-1.12978 http://www.scienceeurope.org/downloads —Jørn Olsen
Lessons learned from the legal protection of data In Europe In June 2013 the European parliament will start the postponed voting on the New Regulation on Data Protection. More than 4000 amendments have been proposed and the Regulation is one of the most lobbied texts in the EU history. Not because of the problems it […]
Evert Ben van Veen has written a summary of the LIBE views and makes comparisons to the proposed data protection regulation. The LIBE proposal will set back epidemiologic research in many European countries if used in the new law. It will threaten free and critical research and the principles of democracy and open societies. […] The matter of data protection regulation has been addressed in a workshop at the last WCE in Edinburgh and the impact that the EU proposal may have on the epidemiologists current work has been debated in some recent papers. The opportunity of harmonising data protection procedures among EU countries has been underlined by some researchers […]
Since our last report, several groups have been active in suggesting modification of the text to facilitate epidemiologic research in Europe. Epidemiologists have contacted members of the European Parliament from their home countries. Ministers of Research have been contacted, and newspaper articles have been published on the topic. Not only epidemiologists have been active. Large […]
Proposal for a Regulation of the European Parliament and of the Council on the protection of individuals with regard to the processing of personal data and on the free movement of such data Comments and follow-up of “EpiBlog: Informed consent” and “EpiBlog: A New EU Directive for Data Protection in Europe”[1] I have […]
Informed consent is a key concept in research ethics, and it has a central place in the Helsinki Declaration. In the randomized clinical trial, participants need to be informed about the potential risks and benefits of the treatment under study in order to make an informed decision before saying yes or no to the invitation […]
It is well documented that NCDs carry an increasing burden of diseases and mortality in affluent as well as poor countries. NCDs amount to 63 % of all deaths in the world, and 80 % of these occur in low and middle income countries (LMICs). Cardiovascular diseases and chronic obstructive diseases are expected to increase […] |
|
|||||||||
|
Copyright © 2017 IEA - All Rights Reserved Powered by WordPress & Atahualpa |
||||||||||
